Nerve ultrasounds may be highly accurate in detecting chronic inflammatory neuropathies, as well as in predicting treatment response.
Hematologic and VEGF nonresponse, and therapy besides autologous stem cell transplantation are risk factors for POEMS progression.
Repeated transcranial direct current stimulation over 5 days was able to reduce pain intensity in patients with chronic neuropathic pain due to multiple sclerosis.
The FDA has approved Qutenza® for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet.
These results that there is a therapeutic window of THC concentrations for treatment of painful diabetic neuropathy.
From 2008 to 2018, there was an increase in shingles vaccination among adults aged 60 years and older, with demographic, socioeconomic, and geographic variations in vaccination rates.
Vitamin D supplements may significantly improve neuropathic symptoms, including pain and quality of life.
Establishing normal values for nerve ultrasound may assist in the evaluation of children with neuropathic disorders.
Diabetic neuropathic pain is associated with depression, anxiety, sleep disorders, and lower quality of life in patients with type 2 diabetes.
Spinal cord stimulation may be more effective than conventional medical management alone for the treatment of painful diabetic neuropathy.